Documentos relacionados

1. Enhanced durability and evolution of retreatment criteria of intravitreal antivascular endothelial growth factor agents for diabetic macular edema.
2. Intravitreal vascular endothelial growth factors hypertension, proteinuria, and renal injury: a concise review.
3. Preserving visual acuity: a compelling 12-year case study of controlling neovascular age-related macular degeneration.
4. Current Treatments for Diabetic Macular Edema.
5. Aflibercept versus Faricimab in the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Review.
6. [Effects of Intravitreal Injection of Anti-vascular Endothelial Growth Factor Drugs on Ocular Blood Vessels and Blood Flow in Patients with Diabetic Retinopathy].
7. Impact of an immersive, interactive medical education initiative on guideline-based retinal disease management knowledge/competence and effectual practice change.
8. Treatment results of diabetic macular edema with different choroidal thickness with intravitreal anti vascular endothelial growth factor.
9. Prevention of vision-threatening complications in diabetic retinopathy: two perspectives based on results from the DRCR Retina Network Protocol W and the Regeneron-sponsored PANORAMA.
10. The role of serum metrics in anti- VEGF treatment for macular edema induced by retinal vein occlusion.